A Phase 1 Dose Escalation Study of VX-973 in Healthy Participants
Status:
COMPLETED
Trial end date:
2025-07-21
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of VX-973 in healthy participants.